SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Onconova Therapeutics warrants (ONTXW)

ONTXW RSS Feed
Add ONTXW Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 8/18/2016 9:52:51 PM - Followers: 2 - Board type: Free - Posts Today: 0

Onconova Therapeutics, Inc., sometimes referred to as "we" or the "Company," is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using our proprietary chemistry platform, we have created an extensive library of targeted anti-cancer agents designed to work against cellular pathways important to cancer cells. We believe that the drug candidates in our pipeline have the potential to be efficacious in a variety of cancers. We have one actively enrolling Phase 3 clinical-stage product candidate and two other clinical-stage product candidates (one of which is being developed for treatment of acute radiation syndromes) and several preclinical programs. Substantially all of our current effort is focused on our lead product candidate, rigosertib.

Read more: http://www.nasdaq.com/symbol/ontxw#ixzz4HjsdlYcz






http://www.nasdaq.com/symbol/ontxw
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ONTXW
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ONTXW News: Onconova Closes Oversubscribed Rights Offering with Gross Proceeds of $17.4 Million 08/01/2016 08:01:00 AM
No posts yet. Be the first!